skip to main | skip to sidebar

NSE-MANTRA

NSE-BSE-TIPS MARKET-NSE CHARTS; GAINERS-LOOSER

SKS Microfinance can cross Rs 500..?

ALL Countries

SENSEX

Labels

  • charts (1)
  • China should increase precious metals reserves (1)
  • Downloads (7)
  • Emerging Economy (1)
  • gold (4)
  • inflation (1)
  • Intra-day tips (6)
  • IPO Details (5)
  • Mahurat Picks 2009 - ICICI Direct (1)
  • market closed (6)
  • MARKET NEWS (21)
  • NSE CLOSING TIME (3)
  • nseindia (1)
  • Our Top Stock Picks For Year 2011 (1)
  • Short-Term tips (31)
  • STOCK TIPS (19)
  • Top Ten Gainers (2)

Blog Archive

  • ► 2017 (1)
    • ► May (1)
  • ► 2015 (6)
    • ► May (2)
    • ► February (2)
    • ► January (2)
  • ► 2014 (6)
    • ► November (1)
    • ► August (1)
    • ► July (1)
    • ► May (1)
    • ► January (2)
  • ► 2013 (42)
    • ► December (1)
    • ► October (2)
    • ► July (4)
    • ► June (5)
    • ► May (4)
    • ► February (25)
    • ► January (1)
  • ► 2012 (5)
    • ► December (1)
    • ► August (3)
    • ► July (1)
  • ▼ 2011 (28)
    • ► August (8)
    • ► June (1)
    • ▼ May (9)
      • Tatas can i...
      • Cement & Construction
      • Energy
      • FMCG
      • Information Technology
      • Pharmaceuticals
      • Telecom
      • NEWS
      • Our Top Stock Picks For Year 2011
    • ► February (5)
    • ► January (5)
  • ► 2010 (28)
    • ► December (1)
    • ► August (1)
    • ► April (1)
    • ► January (25)
  • ► 2009 (74)
    • ► December (7)
    • ► October (16)
    • ► September (51)

Blogger Template by Blogcrowds

Pharmaceuticals

Posted by Nse at Monday, May 16, 2011

Wockhardt in talks to licence drug for Rs 4 bln
Wockhardt in talks to licence Protinex for 4 bln rupees - report
To improve market share, position in Germany: Dr Reddy's
GV Prasad, Vice Chairman and CEO, Dr Reddys Laboratorie...
Regulated markets to fetch Rs 250-300cr in 2 years: Nectar
Dinesh Dua, CEO, Nectar Lifesciences in an interview wi...
Expect to grow 25-28% in FY12: Panacea Biotec
In an interview with CNBC-TV18, Rajesh Jain, Joint MD, ...
Expect to improve EBITDA margin by 75 bps ahead: Lupin
Lupin has declared its fourth quarter results. Kamal K ...
Glenmark Pharma sees its India business growing at 23-24%
Glenn Saldanha, managing director and CEO of Glenmark P...
Elder Pharma sees 21% growth in domestic formulations ahead
In an interview with CNBC-TV18, Alok Saxena, Director (...
Sun Pharma gets US FDA nod for Docefrez injection
A subsidiary of Sun Pharmaceutical Industries has recei...
Court OKs demerger of unit's nutrition biz: Wockhardt
Drugmaker Wockhardt Ltd said on Wednesday the Delhi Hig...
Amrutanjan Health Care approves buy-back of share
Amrutanjan Health Care at its meeting held on May 03, 2.

 

Labels: MARKET NEWS

0 comments:

Post a Comment

Newer Post Older Post Home

Subscribe to: Post Comments (Atom)
 

IPO Information